Suprin Melissa, Chow Allan, Pillwein Marion, Rowe Jonathan, Ryan Martin, Rygiel-Zbikowska Beata, Wilson Kevin Joseph, Tomlin Irene
1 Clinical Development Quality, Pfizer, Inc, Groton, CT, USA.
2 Quality & Compliance Risk Management, Amgen, Thousand Oaks, CA, USA.
Ther Innov Regul Sci. 2019 Jan;53(1):36-44. doi: 10.1177/2168479018817752.
Effective quality risk management is fundamental to ensuring the protection of human subjects and reliability of clinical trial results during the conduct of clinical trials. Quality risk management supports effective delivery of clinical development programs and ultimately delivery of treatments to patients. Thus, risk management is a core element of an effective quality management system (QMS) as described in the TransCelerate Clinical Quality Management System (CQMS) conceptual framework. In addition, the landscape of quality risk management in clinical development evolves as regulatory authorities adopt elements of risk management to promote proactive quality management. This paper's goal is to provide a conceptual framework for quality risk management as part of a CQMS. The components of a quality risk management program are explored including foundational elements and quality risk management methods appropriate for clinical development.
有效的质量风险管理是在临床试验开展过程中确保保护人类受试者以及临床试验结果可靠性的基础。质量风险管理有助于临床开发项目的有效实施,并最终将治疗方法提供给患者。因此,风险管理是如跨加速临床质量管理系统(CQMS)概念框架中所述的有效质量管理体系(QMS)的核心要素。此外,随着监管机构采用风险管理要素以促进主动质量管理,临床开发中质量风险管理的格局也在不断演变。本文的目标是提供一个作为CQMS一部分的质量风险管理概念框架。探讨了质量风险管理计划的组成部分,包括基础要素以及适用于临床开发的质量风险管理方法。